Examining Resources, Initiatives, and Regulatory Pathways to Advance Regenerative Medicine Manufacturing

Purpose of Review The purpose of this review is to provide perspectives and resources for how cell and tissue manufacturing is being advanced by different stakeholders ranging from government to academia to even at a global scale. Recent Findings This perspective article illustrates resources and na...

Full description

Saved in:
Bibliographic Details
Published in:Current stem cell reports 2019-12, Vol.5 (4), p.162-172
Main Authors: Hunsberger, Joshua, Lundberg, Martha S., Allickson, Julie, Simon, Carl G., Zylberberg, Claudia, Beachy, Sarah H.
Format: Article
Language:English
Subjects:
Artificial Tissues (J Hunsberger
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Cell Biology
Chief executive officers
Gene Therapy
Immunology
Life Sciences
Manufacturing
Medicine
Regenerative medicine
Section Editor
Stem Cells
Tissue engineering
Topical Collection on Artificial Tissues
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review The purpose of this review is to provide perspectives and resources for how cell and tissue manufacturing is being advanced by different stakeholders ranging from government to academia to even at a global scale. Recent Findings This perspective article illustrates resources and national efforts that are underway to advance cell and tissue manufacturing. Some of the efforts highlighted are only in their initial years so tangible results are still forthcoming. Summary This perspective article is inspired by a workshop entitled “Cell and Tissue Manufacturing Innovation” that was held at the Tissue Engineering and Regenerative Medicine Society (TERMIS). Five main topics are discussed: (1) the US National Academies’ Forum on Regenerative Medicine, (2) academic translational programs, (3) development of measurements for regenerative medicine, (4) development of standards for ancillary materials, and (5) the global landscape for accelerating regenerative medicine manufacturing. Concepts are presented with current perspective and key insights on challenges, opportunities, and next steps for cell and tissue manufacturing innovation. Several insights are provided that may advance the manufacturing of regenerative medicine products in the USA.
ISSN:2198-7866
2198-7866
DOI:10.1007/s40778-019-00163-0